Global CO2 Laparoscopic Insufflator Market Research Report 2022

Insufflator is the device used for check and surgery of ventral and heart of the body. Insufflator generally employs carbon dioxide (CO2) to generate and maintain the intraperitoneal gas in order to expand the operative field. A insufflator delivers carbon dioxide under low pressure to open up a space within the body, usually to allow a sufficiently large viewing area during endoscopy. According to the USA FDA’s regulation, “a laparoscopic insufflator is a device used to facilitate the use of the laparoscope by filling the peritoneal cavity with gas to expand it”. An insufflator usually consists of host, verses needle, gas (such as CO2) filter, heating unit and power line etc.
Due to the COVID-19 pandemic, the global CO2 Laparoscopic Insufflator market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe CO2 Laparoscopic Insufflator market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe CO2 Laparoscopic Insufflator landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
High Flow Insufflator (≥40 L/min) accounting for % of the CO2 Laparoscopic Insufflator global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Laparoscopy segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of CO2 Laparoscopic Insufflator include W.O.M, Stryker, Karl Storz, Richard Wolf, Olympus, B.Braun, Hoya, STERIS and Fujifilm, etc. In terms of revenue, the global 3 largest players have a % market share of CO2 Laparoscopic Insufflator in 2021.
This report focuses on CO2 Laparoscopic Insufflator volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall CO2 Laparoscopic Insufflator market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global CO2 Laparoscopic Insufflator Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
High Flow Insufflator (≥40 L/min)
Middle Flow Insufflator (20-40 L/min)
Low Flow Insufflator (<20 L/min)
Segment by Application
Laparoscopy
Bariatric Surgery
Heart Surgery
Other Surgery
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
W.O.M
Stryker
Karl Storz
Richard Wolf
Olympus
B.Braun
Hoya
STERIS
Fujifilm
Smith & Nephew
Bracco
CONMED
Northgate Technologies
Shiyin Medical
Arthrex
GIMMI GmbH
Hawk
Tonglu Jingrui
Kangyou Medical